Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 1.000 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.490 | |
| 3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.480 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.476 | |
| 4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.476 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.474 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.470 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
| 2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
| 3aba | FLI | Cytochrome P450 | / | 0.464 | |
| 3cth | 319 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.464 | |
| 3f82 | 353 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.464 | |
| 4qrc | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.456 | |
| 3eta | 351 | Insulin receptor | 2.7.10.1 | 0.452 | |
| 3ce3 | 1FN | Hepatocyte growth factor receptor | 2.7.10.1 | 0.449 | |
| 4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.449 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.443 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.442 |